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Abstract
Introduction: Identifying the optimal timing and frequency of universal depression screening
during pregnancy can optimize the current national recommendations. Identifying whether a
protocol for universal depression screening is beneficial in obstetric clinics. This integrative
review of published literature explored the optimal timing, frequency, and feasibility of universal
antenatal depression screening.
Methods: A literature search using CINAHL, PubMed, and Google Scholar identified published
and original articles associated with universal antenatal depression screening. Articles were
included if they pertained to the topic, were published within the last 6 years, were peer
reviewed, available in English, and contained quality evidence. The included studies were
screened using a web-based application while organizing them into the PRISMA flow diagram.
The results were disseminated into three categories using King’s theory of goal attainment:
personal, impersonal, and social.
Results: The search identified 543 articles, of which 17 were included in this review. The 17
studies identified the depression screening during every prenatal visit as the optimal frequency,
and the least optimal frequency being once during pregnancy. The studies also identified
screenings taking place during the intake and first trimester prenatal visit as optimal timing.
Lastly, a universal depression screening protocol during pregnancy screened a higher number of
patients, which in turn increased the number of women seeking mental health services while
pregnant.
Discussion: Despite the limited amount of research on the topic, the results showed the need for
universal antenatal depression screening protocols in every obstetric clinic. Screening during
pregnancy should take place more than once and should include intake and the first trimester
visit. The results are clinically significant for obstetric practice providers since they offer a more
refined recommendation for depression screening during pregnancy. Gaps in the research, which
include barriers to universal screening and consistent thresholds for positive Edinburgh
Postpartum Depression Screen results need to be addressed.
Keywords: Universal depression screening protocol, depression screening, pregnancy,
antenatal, prenatal care, Edinburgh Postpartum Depression Screen
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Universal Depression Screening in Pregnancy
Perinatal depression is one of the most common obstetric complications, impacting up to
25% of all pregnancies (Adane et al., 2021). Perinatal depression has been linked to a higher
chance of stillbirth, fetal mortality, infant mortality, low birth weight babies, and preterm
delivery (Adane et al., 2021). The U.S. Preventive Services Task Force (USPSTF) recommends
that all pregnant women should be universally screened for depression (Siu & the U.S.
Preventive Services Task Force, 2016). Universal antenatal depression screening means that all
women, despite their risk factors, should be given a brief screening to identify depressive
symptoms during their pregnancies.
Most of the evidence for this recommendation was based on previous research showing a
large decrease in postpartum depression risk after universal screening protocols were employed
in the postpartum period (O’Connor et al., 2016). O’Connor et al. (2016) stated that universal
postpartum depression screening reduced the risk for postpartum depression by 28%–59%.
Wisner et al. (2013) also identified that postpartum depression may start before pregnancy or
during the antenatal period.
The American College of Obstetrics and Gynecology (ACOG, 2018) adopted the
USPSTF’s recommendation that universal perinatal depression screening should occur at least
once during pregnancy using a validated screening tool. The American College of NurseMidwives (ACNM, 2020) also adopted these recommendations but stated that universal perinatal
depression screening using a validated screening tool should occur at least twice during
pregnancy.
Universal perinatal depression screening is a newer concept that may not be fully
initiated in every obstetric prenatal clinic. Since there are not enough details in the USPSTF,
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ACOG, and ACNM recommendations, prenatal providers are left to their own discretion when it
comes to initiating screening and its frequency. The purpose of this integrative review was to
address these inconsistencies and to help ensure that pregnant women are universally screened
for depression by answering the following questions: What is the optimal timing and frequency
of universal perinatal depression screening during pregnancy? and, Is universal screening
feasible for obstetric clinics?
Framework
Imogene King’s theory of goal attainment provided the framework for this integrative
review. This theory was developed in the 1960s to describe dynamic interpersonal relationships
in which patients attain certain life goals through personal growth and development (Petiprin,
2020). King focused on the patient’s health as being the main goal with three interacting
systems: personal, interpersonal, and social.
The theory posits that nurses’ goals should be to help patients maintain their health,
which allows normal functioning in the patient’s roles (Petiprin, 2020). King identified the
interactions with patients as a step in attaining this goal. During pregnancy, an obstetric provider
interacts with patients during many prenatal appointments. The goal set for pregnant women is to
have a healthy pregnancy and an easy transition to their roles as mothers. The changes in
pregnancy may cause a new onset or flare up of depression, which could impact a pregnant
women’s goals. Administering universal depression screenings at the correct time and frequency
could positively impact the three systems King identified.
The frequency of how often screening should be completed in pregnancy addresses the
needs patients may experience related to their personal systems during pregnancy. King’s
nursing theory of goal attainment describes the personal system as the body image, development,
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self-image, and one’s perception (Petiprin, 2020). The personal system may fluctuate many times
while experiencing the physical and emotional changes from pregnancy. The interpersonal
system is characterized as the part that consists of interactions, communication, transaction, role,
or stress (Petiprin, 2020). When depression screening takes place may help pregnant women
cope with any of these areas in the interpersonal system.
Lastly, the social system of King’s nursing theory of goal attainment covers the
relationship that the patient establishes with the provider in the obstetric clinic. Interactions in
the clinic setting can help patients with decision-making, roles of power, status, and organizing
goals (Petiprin, 2020). Establishing universal screening in obstetric settings can address the
social needs of pregnant patients and allow them to identify depressive symptoms while also
offering enough time to seek the necessary treatments.
Methods
Whittemore and Knafl’s (2005) methodology and framework guided this integrative
review. This integrative review followed the recommended steps using this methodology and
framework in which a problem was identified, a literature review search was conducted, and the
data were evaluated and analyzed. The preferred reporting items for systematic review and metaanalysis (PRISMA) guidelines were used to verify the search strategy. The literature search was
conducted after a consultation with a Bethel University librarian on recommendations for
databases and to determine the keywords, which were the following: universal perinatal
depression screening, depression screening, pregnancy, antenatal depression screening, prenatal
care, PHQ-9 (Patient Health Questionnaire-9), and the Edinburgh Postpartum Depression Screen
(EPDS). The literature searches took place in the CINAHL, PubMed, and Google Scholar
databases and an ancestry search, using the following search terms: perinatal depression,
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depression screening, universal depression screening, prenatal care, pregnancy, Edinburgh
Postpartum Depression Screen, and PHQ-9.
Articles from the searches were uploaded into the web-based software Covidence for the
screening process. A total of 550 articles were imported. 202 duplicates were removed. Each
article’s title and abstract were reviewed for relevancy, which yielded 61 articles. The full-text
articles were then examined for eligibility, and 44 articles were excluded from review. The
articles were evaluated for study design, outcome measurements, population, quality, and level
of evidence. Inclusion criteria for this integrative review consisted of original qualitative or
quantitative research, peer-reviewed articles, published research, English language, published
within the last 6 years, and relevant studies that addressed the chosen topic. Exclusion criteria
included studies on different populations than the present study, different interventions than the
present study, or measured outcomes different from those in the present study.
Using these criteria, 17 articles were identified and included in the integrative review.
Figure 1 displays a PRISMA flow diagram which was chosen to report the search screening
process. Table 1 summarizes the studies included in this review, offering a brief synopsis of each
study’s design, recommendations, strengths, limitations, and level of evidence. Levels of
evidence were measured using the John Hopkins Evidenced-Based Practice Model (JHEBDM)
using appendix D. This appendix summarizes how to determine the level of evidence and quality
grade. The levels of evidence are the following: Level I; experimental, Level II; quasiexperimental, Level III; nonexperimental, Level IV; expert opinions in clinical practice, and
Level V; nonresearch and experiential evidence. The quality grades consist of A; high quality, B;
good quality, and C; bad quality or major flaws.
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After the final studies for review were established, the results were then disseminated into
three categories using King’s theory: timing and interpersonal system; frequency and personal
system; and feasibility of a universal depression screening in an obstetric clinic and the social
system.
Results
Summary of Articles
The 17 studies identified that fit the criteria for the present review were conducted in
various geographic locations, including China, Australia, and the United States. The samples
consisted of pregnant and postpartum women, and the sample sizes ranged from 77 to 102,906.
The samples also reflected a diverse population with multiple ethnicities (Black, White,
Hispanic, Asian, and other), cultures, and socioeconomic backgrounds. Methodology in the
studies varied, with 10 retrospective cohort studies, three quality improvement studies, one
mixed methods study, one survey, one longitudinal study, and one cross-sectional study. Using
the tool from JHEBDM the articles included were found to be of the following evidence levels
and quality grade: one study at Level II, 12 studies at Level III, one study at Level IV, and three
studies at Level V. No studies reflected Level I. All the studies contained high-quality evidence
since each included adequate sample sizes, consistent and generalizable results, definite
conclusions, and a thorough evidence review.
The evidence was organized using the framework from King’s theory and placed into
three categories: frequency and personal system, timing and interpersonal system, and feasibility
of a universal depression screening in an obstetric clinic and social system. Table 2 is a summary
of the results.
Frequency and Personal System

10

Screening Once.
Of the 17 studies, two (Ellington, 2021; Venkatesh et al., 2016) measured the results from
screening depression once during pregnancy. Venkatesh et al. (2016) screened pregnant women
during a third trimester appointment and during a 6-week postpartum visit. Of the 8,985 women
screened, 6.5% screened positive using the EPDS. The positive screens included 69%
antepartum and 31% postpartum women (p < .01). The positively screened antepartum patients
were more likely to seek mental health services when compared with positively screened
postpartum patients (83% versus 71%, p < .01). Following these women after delivery, the
antepartum women who were linked to mental health services were less likely to have a positive
screen 6 weeks postpartum compared with those who were not linked to mental health services
(20% versus 82%, p < .0001). Ellington (2021) reported that 24 of 77 patients (31.17%) were
positively screened during intake visits, which averaged between 8–12 weeks gestation.
Screening Twice.
Four studies (Avalos et al., 2016; Long et al., 2020; Mestad et al., 2016; Miller et al.,
2019) reflected screening twice for depression during pregnancy. Avalos et al. (2016), Long et
al. (2020), and Miller et al. (2019) stated that they chose to screen twice since it was easier to add
these screens during the intake and glucola screening visits.
Avalos et al. (2016) initiated a health care-system-wide protocol for universal screening
with the goal of screening pregnant women at least two times during pregnancy and one time
postpartum using the PHQ-9. After full implementation of the protocol, 97% of pregnant women
were screened at least once, and 89.1% of these women were screened twice or more (p < 0.001).
A new diagnosis of depression and its severity increased from preimplementation to
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postimplementation (depression, 8.2% versus 11.7%, p < 0.001; severity, 0.2% versus 3.1%,
p < 0.001).
Mestad et al. (2016) reviewed the statistics associated with screening for depression
during pregnancy in an obstetric clinic. The results showed that pregnant women were screened
at least once 84% of the time and at least twice 50% of the time. The women who received only
one screening either entered prenatal care late or after their first trimester. Of the women who
were screened for depression, 27% screened positive once and 13% screened positive twice
(Mestad et al., 2016).
Miller et al. (2019) found that 8.6% of study participants screened positive in the first
trimester, 6.6% screened positive in the third trimester, and 1.2% screened positive at the 6-week
postpartum visit. Long et al. (2020) found higher screening rates in intake and postpartum
appointments (60.14% and 85.45%) when compared with the glucola screening appointment
(35.01%). Clinically significant EPDS scores were 18.21% at intake, 17.43% at the glucola
screening appointment, and 13% at the 6-week postpartum visit. Long et al. concluded that the
screening rates and clinically significant EPDS scores showed that depressive symptoms can
increase or decrease throughout pregnancy and after.
Screening Three or More Times.
Studies in which depression screens occurred three or more times (Guo et al., 2021;
Wilcox et al., 2019; Yu et al., 2020) offered perspectives on trajectories of depression for
pregnant and postpartum women. Wilcox et al. (2019) evaluated several groups of pregnant
beginning at either the first or third trimesters. This study was not associated with an obstetric
clinic; its purpose was to interpret the data received from pregnant and postpartum women.
Multiple EPDS screens administered during pregnancy and postpartum showed that the highest
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depressive incidents (EPDS score >14) occurred during pregnancy: 33% first trimester, 24%
second trimester, 22% third trimester, 13% 4 weeks postpartum, and 8.4% 3 months postpartum.
Wilcox et al. also found that women with high EPDS scores did not necessarily persist there.
Guo et al. (2021) screened pregnant women during the first, second, and third trimesters
and offered several conclusions from their findings. The results showed that gestational age
(p = 0.014) and gestational weeks (p < 0.001) were significant for antenatal depression diagnosis.
Another conclusion from the results was women in the first trimester had a higher risk for
depression compared to the women in the second, AOR = 0.611, 95% CI [0.483, 0.773] and third
trimesters, AOR = 0.337, 95% CI [0.228, 0.498].
Yu et al. (2020) identified three trajectories of depressive symptoms during pregnancy
and postpartum among women who were screened seven times. Ninety percent of the women
screened had no depressive symptoms throughout their pregnancy and postpartum, 5.1% had
higher EPDS scores during pregnancy, and 4.9% had higher EPDS scores postpartum. Just over
52% of the women had their first onset of depressive symptoms during pregnancy, with 26.8% of
these women having their highest EPDS score between 12–24 weeks gestation. The highest
EPDS scores were during visits between 12–24 weeks gestation and 1 week postpartum (Yu et
al., 2020).
Timing and the Interpersonal System
EPDS Scores During the First Trimester.
A number of researchers conducted studies in which trimester EPDS and PHQ-9 scores
were compared to postpartum scores (Ellington, 2021; Guo et al., 2021; Lomonaco-Haycraft et
al., 2018; Long et al., 2020; Tourtelet et al., 2020; Wilcox et al., 2019; Yu et al., 2020). An
overwhelming amount of evidence showed that pregnant women screened higher for depression
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during the first trimester (Ellington, 2021; Guo et al., 2021; Lomonaco-Haycraft et al., 2018;
Long et al., 2020; Tourtelet et al., 2020; Wilcox et al., 2019; Yu et al., 2020). Guo et al. (2021)
reported that 18.1% of pregnant women were positively screened during the first trimester,
which was the highest reported positive trimester screening comparing with the second and third
trimesters. Lomonaco-Haycraft et al. (2018) reported that 21.52% of women in the first trimester
were positively screened, which was higher than the third trimester and postpartum screens.
Long et al. (2020) reported that clinically elevated EPDS scores were 18.21% at the first
trimester, making this the highest percentage of significant scores when compared with the third
trimester and postpartum scores. Tourtelet et al. (2020) was a mixed methods study in which
pregnant women were screened during their first prenatal appointment and followed if they
received treatment after a positive screen. Fifty-eight of the 393 women screened positive
(Tourtelet et al., 2020).
Ellington (2021) found that 31.17% of pregnant women screened positive at their intake
visit, which averaged between 8–10 weeks gestation. Wilcox et al. (2019) stated that in Cohort 1
in their study, which included women in their first trimester, 10% had positive screens at
baseline, which increased at the end of the first and second trimesters, rising to 13% in each
trimester. Yu et al. (2020) found that 5.1% of pregnant women screened positive during the first
and second trimesters, which was slightly higher than the postpartum group at 4.9%. During the
first trimester, the EPDS scores ranged from 6 to 16 points (Yu et al. 2020).
EPDS Scores During Second and Third Trimesters.
Results from Guo et al. (2021), Lomonaco-Haycraft et al. (2018), Long et al. (2020),
Venkatesh et al. (2016), Wilcox et al. (2019), and Yu et al. (2020) showed lower second and
third trimester scores compared with first trimester scores. In Guo et al., the risk of depression
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was lower in the second trimester, AOR = 0.611, 95% CI [0.483, 0.773] and third trimester,
AOR = 0.337, 95% CI [0.228, 0.498] when comparing positive screening rates to the first
trimester. Guo et al. also concluded that gestational age (p = 0.014) and gestational weeks
(p < 0.001) were contributing factors to antenatal depression.
Lomonaco-Haycraft et al. (2018) screened only 37% of pregnant women at the 28-week
visit, and 16.04% screened positive, which was 5% lower than in the first trimester. Long et al.
(2021) reported clinically elevated EPDS scores (17.43%) at the glucola screening appointment.
Venkatesh et al. (2016) determined that 69% of the women screening positive were antepartum
screenings. Wilcox et al. (2019) reported that the positive screen percentage rose to 16% in
Cohort 1 in their study, which consisted of women during their first trimester, compared with the
baseline of 10% and second trimester screen of 13%. Cohort 2, which consisted of women
during the beginning of the third trimester, had a baseline score of 12.7% screening positive,
which decreased to 10.7% by the end of the third trimester. Yu et al. (2020) concluded that the
highest EPDS scores during pregnancy happened during the second trimester, between Weeks 12
and 24. Scores during the third trimester remained stable, with a possible higher trend for the
pregnant women who would eventually screen positive during their postpartum screenings (Yu et
al., 2020).
Feasibility and the Social System
Screening Rates: No Established Protocol for Universal Screening.
Several studies (Fedock et al., 2018; San Martin Porter et al., 2019; Sidebottom et al.,
2020) included demonstrated screening rates of obstetric clinics without a universal screening
protocol established. Sidebottom et al. (2020) researched a large health care system and reviewed
the screening rates throughout. Pregnant women were screened 65.1% of the time, with 34.9%
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not screened at all. Of the pregnant women who were screened, 52% were screened once and
13.3% were screened two or more times. Screenings ranged widely among 35 obstetric clinics,
with the low being 34.7% and the high being 100% of patients screened for depression while
pregnant. Sidebottom et al. recognized that women with a documented history of anxiety and
depression and those who had a larger number of prenatal visits were more likely to be screened,
AOR 2.18. Women who spoke a language other than English were less likely to be screened,
AOR 0.74.
Fedock et al. (2018) researched the difference in screening rates among pregnant and
postpartum women. After reviewing the data, the researchers concluded that obstetric providers
were less likely to universally screen pregnant women (53.04% versus 82.40%, p < 0.001) and
less likely to offer guideline-congruent care (33.61% versus 58.51%, p < 0.001) to pregnant
women compared to postpartum women. Fedock et al. observed several factors that influenced
whether the obstetric provider screened pregnant women. The clinics that screened were more
likely to have onsite mental health services, higher satisfaction rates working with mental health
services, and previous experience with universally screening pregnant women. Fedock et al.
concluded that personal motivation was the largest influence on whether obstetric providers
screened for depression during pregnancy.
San Martin Porter et al. (2019) reported differences in screening rates among public and
private hospitals in Queensland, Australia. The public hospitals initiated a universal screening
protocol for all pregnant women, whereas the private hospitals had not initiated universal
screening at the time of the study. Just over 71% of pregnant women were screened in public and
private hospitals. Significantly fewer pregnant women in the private hospitals were screened
compared to public hospitals (28.8% versus 91.0%, p < 0.001).
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Screening Rates Before and After Protocol Implementation.
Many of the studies included in the current review compared screening rates before and
after implementing a universal screening protocol for pregnant women (Avalos et al., 2016;
Gisseman et al., 2021; Lomonaco-Haycraft et al., 2018; Miller et al., 2019, 2021; Puryear et al.,
2019). Avalos et al. (2016) concluded that prior to implementation pregnant women were
screened less than 1% of the time, and that after implementation 98% of women were screened at
least once during pregnancy (p < 0.001). Gisseman et al. (2021) used a universal screening
protocol and reported screening rates to be highest at intake (95%–97%) and lowest during the
third trimester (48%–60%).
Lomonaco-Haycraft et al. (2018) found the screening rates improved from 0% prior to
implementation to greater than 75% after. Miller et al. (2019) found significant improvement in
screening rates after implementation for the first trimester (0.1% preimplementation versus
65.5% postimplementation, p < .001) and third trimester (0.0% preimplementation versus 42.7%
postimplementation, p < .001). Miller et al. concluded that antenatal patients who received
prenatal care after implementation were more likely to be screened (33% versus 81%, AOR
58.5). Puryear et al. (2019) found that 27% of pregnant women were screened at 11–13 weeks
and 47% were screened at 35–37 weeks after implementation, demonstrating a 14%–91%
compliance among four different clinics.
Benefits of Universal Screening.
Findings in several studies (Avalos et al., 2016; Ellington, 2021; Lomonaco-Haycraft et
al., 2018; Long et al., 2020; Miller et al., 2019, 2021; Venkatesh et al., 2016) identified specific
areas in which universal screening helped pregnant women. Avalos et al. (2016) reported more
women receiving treatment after screening when comparing percentages before and after
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implementation (5.9% versus 81.9%, p < 0.05). New depression diagnoses also increased after
implementation (8% versus 12%, p < 0.001). In Ellington (2021) and Miller et al. (2021), more
patients were able to seek mental health services since higher numbers of patients were referred.
In Miller et al. (2019), the number of providers referring patients for mental health services
increased, p < 0.001.
Lomonaco-Haycraft et al. (2018) identified greater enthusiasm for screening patients
among providers and clinics, which helped more patients receive referrals for mental health
services. Venkatesh et al. (2016) observed that antepartum patients were more likely to seek
mental health services when compared with postpartum patients (83% versus 71%, p = .002).
Discussion
Summary Methods and Theory Integration
Depression has been identified as the most common obstetric complication. As such, the
USPSTF (2016) recommends universal depression screening but does not specify screening,
timing, frequency, or feasibility during the antenatal period (Adane et al., 2020). Addressing
these key elements of antenatal depression screening could help reduce the impact of one of the
most common obstetric complications (Adane et al., 2020). Findings from the 17 articles
reviewed for the current study contributed evidence for recommending the optimal frequency,
timing, and feasibility of universal depression screening in obstetric clinics.
Frequency and the Personal System
Depression screening scores can increase or decrease throughout pregnancy (Long et al.,
2020). Yu et al. (2020) had similar findings after screening pregnant women throughout both
pregnancy and postpartum, which showed that new onset of depression can occur at any point
during pregnancy. Screening at every prenatal visit allows providers to quickly identify and
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address new onset depression, making this frequency most optimal (Long et al., 2020; Wilcox et
al. 2019; Yu et al., 2020). This frequency may increase the amount of time for each prenatal
visit, which may not be feasible for every obstetric practice. The least optimal frequency for
screening during pregnancy would be once (Long et al., 2020). When or if pregnant women will
screen positive during pregnancy cannot be predicted. Only addressing depression once during
pregnancy may cause depressed women to go undiagnosed, which was evidenced by the
inconsistent screening rates seen in several articles (Ellington, 2021; Long et al., 2020;
Venkatesh et al., 2016).
Timing and the Interpersonal System
This integrative review showed that the first trimester is the most optimal time to screen
pregnant women for depression (Ellington, 2021; Guo et al., 2021; Lomonaco-Haycraft et al.,
2018; Long et al., 2020; Tourtelet et al., 2020; Wilcox et al., 2019; Yu et al., 2020), with the
second trimester also effective (Wilcox et al., 2019; Yu et al., 2020) and the third trimester the
least effective (Lomonaco-Haycraft et al., 2018; Wilcox et al., 2019; Yu et al., 2020). Screening
in any trimester provided more pregnant women access to mental health resources (Ellington,
2021; Lomonaco-Haycraft et al., 2018; Miller et al., 2021). Considering that antepartum women
are more likely to seek mental health services, these results support implementing screening
during the first trimester (Venkatesh et al., 2016).
Feasibility and the Social System
Findings from this integrative review also showed that a universal depression screening
protocol during pregnancy is feasible for obstetric clinics (Avalos et al., 2016; Gisseman et al.,
2021; Lomonaco-Haycraft et al., 2018; Miller et al., 2019, 2021; Puryear et al., 2019). Screening
was more feasible when obstetric clinics included a standard protocol, easy access to mental
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health services, health care workers who were trained prior to implementation, and screening
integrated into their electronic medical records (Fedock et al., 2018; San Martin Porter et al.,
2019; Sidebottom et al., 2020). San Martin Porter et al. (2019) demonstrated the differences
between obstetric clinics having a universal screening protocol and those without. Other
researchers demonstrated large differences between the number of pregnant and postpartum
women screened before and after a universal depression protocol was implemented (Avalos et
al., 2016; Gisseman et al., 2021; Lomonaco-Haycraft et al., 2018; Miller et al., 2019, 2021;
Puryear et al., 2019), showing that more pregnant women were screened when a universal
protocol was in place.
Research Gaps
Findings from this integrative review reflect several gaps in the research on universal
screening that should be addressed. The first gap is whether screening positively impacts
antenatal depression and its associated obstetric and neonatal outcomes. The recommendations
for universal screening during pregnancy are rather new, and it is important to measure the
universal screening’s impact on outcomes.
Secondly, barriers to screening should be researched. The results from this integrative
review showed that barriers still exist after implementing a protocol, causing less than 100% of
pregnant and postpartum women being screened. Examples of barriers identified in the literature
that should be included in future research are provider bias and patient characteristics. Universal
screening offers a solution to minimize provider bias and allow more pregnant women to be
screened for depression. Influences from patient characteristics and their correlated screening
rates should be studied. Characteristics that should be studied include race, ethnicity, cultural
background, language, sexual orientation, and socioeconomic status.
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Lastly, despite having EPDS being validated for pregnancy screenings (Rubertsson et al.,
2011), variations in the thresholds for screening still existed among the articles included in the
present integrative review. Research is needed to investigate the optimal standardization of
scores, especially in the antenatal period. Further research is needed to determine the optimal
threshold during pregnancy for referrals to mental health services.
Review Limitations
A variety of limitations were present in this study. The evidence level in this review was
low since the 17 included articles did not reflect experimental, quasi-experimental, or
randomized control trials. Additionally, the review was limited by variations in threshold scores
when positive depression screenings were present. Standardization of EPDS scores should be
addressed in a universal depression protocol during pregnancy to help providers know when to
refer and treat and to promote quality research. Lastly, this review was limited by the amount of
extant research and evidence on universal depression screening during pregnancy.
Impact for Advanced Practice Providers
This integrative review is important for advanced practice providers who work in
obstetric clinics. Addressing patients’ personal, interpersonal, and social systems by universally
screening every pregnant woman can help address the most common obstetric complication. If
providers are screening for depression early in pregnancy, patients are more able to access
mental health services, which hopefully will reduce the associated risks with depression during
pregnancy. Ensuring that providers screen during optimal times and screen the optimal number
of times during pregnancy is another important consideration. As previously discussed, optimal
screening procedures will help to address fluctuations in depressive symptoms pregnant women
can experience during pregnancy. Lastly, by screening appropriately, advanced practice
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providers can help patients receive the mental health services they need. Universally screening
all women will help to identify a higher number of depressed pregnant women and allow more of
them to access mental health treatment.
Conclusion
To address the identified gap in research, this integrative review was guided by the
methodology and framework in Whittemore and Knafl (2005), which helped disseminate the
research into three categories using King’s theory of goal attainment. Patients’ three systems––
personal, interpersonal, and social––are impacted when providers optimally screen for
depression during pregnancy. Screening frequency can positively impact patients’ personal
systems. The interpersonal system can be addressed by screening patients for depression at the
correct time. Lastly, the social system can be influenced by the obstetric clinic prioritizing
depression screens for all patients during their pregnancies. The results from this integrative
review addressed these questions: What is the optimal timing and frequency of universal
perinatal depression screening during pregnancy? and, Is universal screening feasible for
obstetric clinics?
Pregnant women are a vulnerable population, making them at high risk for depression
(Adane et al. 2021). It is imperative that obstetric clinics establish a universal antenatal
depression screening protocol. Screening should take place more than one time during pregnancy
to ensure that first trimester or intake visits are included in screening protocols. The present
study’s evidence helped to fill the gaps in vague recommendations from ACOG and ACNM by
addressing the details of screening for depression during pregnancy.
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Level Retrospective
Observational
2020
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pregnant
A
women

Venkatesh
et al., 2016
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III
A

Retrospective
Cohort Study,
8985 pregnant
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Study aim
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frequency of
screening for
perinatal
depression,
rates of the
Edinburgh
Perinatal
Depression
Screen (EPDS),
and treatment
recommendatio
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strongest
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elevated EPDS
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implementation
of universal
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depression
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pregnancy and
postpartum
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Screening
tool;
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Results

Recommendations
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-Screening rates: Intake
60.14%, Glucola test 35.01%,
and Postpartum 85.46%.

-Screening for
depression should
take place at every
prenatal visit to
ensure patients
who need
treatment are not
missed.

Limitations:
-Assessing screening and treatment at
only one obstetric clinic

-Universal
screening is
feasible for
antepartum and
postpartum
patients using the
EPDS.

Limitations:
-Clinical characteristics of the women
who screened positive were not
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-The highest rate of elevated
EPDS scores was at intake.

-Screening rates: Antenatal
98% and Postpartum 86%
-Highest number of elevated
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pregnancy, Antenatal 69% and
Postpartum 31%
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evaluation during pregnancy
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parameters for EPDS scores.
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-Same EMR to access records, ease of
referral process, and ease of
screening.
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-Large sample size

treatment rates. Antenatal 83%
and Postpartum 71%
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2019

Level
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A

Avalos et
al., 2016

Level
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A

-Retrospective
Cohort Study,
5127 pregnant
women; late
prenatal care
and preterm
deliveries
were
excluded.

-Whether an
initiation of
universal
perinatal
depression
screening
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sustained its
frequency

-Populationbased
Retrospective
Cohort Study,
97,678
pregnant
women

-To evaluate if
universal
prenatal and
early postnatal
depression
screening leads
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diagnosis,
intervention,
and improved
depressive
symptoms
outcomes

-Unable to
determine
screening tool

-Screening rates before policy
were implemented and after
policy: First prenatal visit
0.1% vs 65.5%, third trimester
-Screening
0.0% vs 42.7%, postpartum
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within the 1st
-Rates for screening during
trimester, 3rd
trimester, and pregnancy increased overtime,
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6-week
consistent
postpartum.
-Screening rates: 1% prePHQ-9
implementation of universal
screening and 97.5% after
-Screening
screening
during early
pregnancy, 0-All three perinatal time
20-weeks
gestation, late periods screened only 49%
pregnancy 20- after implementation
compared to 0% preweeks
gestation until implementation
delivery, and
-Those receiving a new
6-week
depression diagnosis after
postpartum
screening, 11.5% compared
visit. Goal of
prior to policy change 0.4%
3 times total

mental health
services to have an
official diagnosis
and treatment
plan.
-Universal
depression
screening can be
integrated into
routine prenatal
care
-Implementing a
universal perinatal
depression policy
increased
screening and
treatment of
pregnant women
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-unable to determine screening tool
-observational study which may be
impacted by the secular changes
overtime
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-Large sample size

-Universal
perinatal
depression
screening
protocols are
feasible and
increase screening
rates.
-Universal
perinatal
depression
screening should
be initiated within
obstetric clinics

-Detailed chart review process
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-Symptom comparison between
before and after implementation could
not happen since there was a lack of
follow up screening prior to
implementation
-Referral and treatment rates were not
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the success from screening and
outcomes.
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-large sample size

Sidebottom
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A

San Martin
Porter et al.,
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-Retrospective
Cohort Study,
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pregnant
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had at least 3
prenatal visits.

-crosssectional
retrospective
study, 30,468
pregnant
women

-Assess the
prevalence of
depression
screening in the
prenatal and
postnatal
periods within
a large health
system.
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disparities in
practices and
variables of
screening.

PHQ-2
triggers the
full PHQ-9

-To investigate
screening rates
of public
hospitals with
universal
screening
protocols and
private
hospitals
without

EPDS

-Measures
screening
during
pregnancy and
postpartum,
does not
specify
gestational age
when
screening
occurred

-Screened one
time during
pregnancy

-Screening rates, Antenatal
63.3% and Postpartum 64.1%
-Of note, this study compared
measurable screening rates to
self-reported screening rates
from providers. 63.3%, 64.1%
vs 98%. 95% of providers
overestimated their personal
screening rates.
-Racial and socioeconomic
disparities exist when
measuring the difference in
screening rates compared to
patient characteristics.
-Screening rates at public
standardized obstetric facilities
91.0% and private obstetric
facilities 28.8%

- Providers who
screened their
patients had
screening built
into EHR,
previously
implemented a
universal perinatal
depression
screening
protocol, and
included a nurse to
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standardized
practices for
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-Universal
perinatal
depression
screening
protocols increase
the number of
women who are
screened.

-Research over a long period took
place.
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-Results were limited to the
information included in the EHR.
-This study may not have the ability
to generalize to all pregnant women
since this geographical area consists
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-An entire health system was included
in the study which identified areas of
needed change for universal perinatal
depression screening.
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-Analyzing health data may not
identify every piece of needed
information.
-EPDS was the only screening tool
evaluated. There may have been other
screening tools used within the
private hospitals.
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-EPDS is a validated screening tool to
measure
-No recall bias existed within the
study
-Timeframe of measuring the data
was 4 years after the protocols were
changed allowing enough time to
adopt the recommended changes.

Puryear et
al., 2019

Level
V
A

Fedock et
al., 2018

Level
IV
A

Tourtelot et
al., 2020

Level
III

-Quality
Improvement
102,906
pregnant
women

-Summary of
a survey from
randomized
OBGYN’s
utilizing the
total design
method, 483
OBGYN
responses

-mixedmethods
study,

-To evaluate if
a quality
improvement
plan for
universal
perinatal
depression
screening was
effective

-To test the
conceptual
model of
provider
decisionmaking. Also
identify if a
difference
exists between
pregnant and
postpartum
women being
screened for
depression.

-To evaluate
positive
depression

EPDS
-Screened at
the first
trimester, third
trimester, and
postpartum
visit

-Screening results: first
trimester 27%, third trimester
47%, and postpartum 26%
-Screening results from the 4
sites ranged from 14%-91%

-OBGYN’s reported surveying
pregnant women for
depression often, always
-Measure
53.04% of the time compared
universal
to postpartum women often,
depression
screening once always 82.30% of the time.
during
pregnancy and -OBGYN’s who completed
screening during pregnancy
once
were most likely to have onsite
postpartum.
mental health services, higher
levels of satisfaction when
coordinating referrals with
mental health services, and
twice as likely to have
universal screening protocols
within the health facility as a
priority.
n/a

EPDS

-Screening percentage: 393
were screened with the EPDS
at their first prenatal visit.

-Planning,
training, and
implementation of
a universal
depression
screening program
can be initiated to
achieve high
screening and
referral rates.

-Identifies
disparities for
pregnant women
versus postpartum
women being
screened for
depression.

Limitations:
-This study may not have the
replicability since the providers all
shared one EMR
-Low number of women with
Medicaid included in this study.
Strengths:
-Every provider shares the same EMR
which allows easy access to mental
health and referrals
-Integrated Behavioral health
Limitations:
-Provider gender was not identified
-The study relied on self-report
instead of observing practices.
-Universal perinatal depression
screening recommendations may
change or end in the future which
may impact the direction of future
research on this topic
-Only OBGYN obstetric providers
were included
Strengths:
-Direct response from providers to
gain feedback on practices for
depression screening.

-Address barriers
that may limit the

-Newer idea of comparing practices
and protocols for antepartum and
postpartum patients.
Limitations:
-non-English speaking patients were
excluded from the study

A

pregnant 408
women

screening
responses of
obstetric
providers with
an integrated
team approach
-To evaluate
patient
perspectives.

Wilcox et
al., 2019

Level
II
A

-The sample
of women
were found
through the
babycenter
online
platform
owned by
Johnson &
Johnson. 858
were in the
first trimester
cohort. 321
were in the
third trimester
cohort.

-To describe
perinatal
depressive
symptoms,
onset, and
trajectory

-Screening at
the first
prenatal visit
and 6-week
postpartum
visit

Mean gestation was 13.1
weeks.

-Patient perception of
screening and follow-up: 1
patient shared she did not
think her mood needed a
psychotherapy referral she
would just follow up with the
provider at her next prenatal
appointment, 1 patient
accepted a referral, but never
attended the appointment, 1
said she did not expect to
follow up at all, 1 said she was
nervous about getting
postpartum depression that is
why she accepted medication,
but wants to make sure her
baby is safe during pregnancy
-First trimester cohort results:
EPDS, PSS,
STAI, GAD-7, Baseline 10% of women
scored probably mild
PHQ-2,
depressive disorder (MDD),
PerinatalPTSD, and the end of first and second
trimester rose to 13%, end of
PROMIS
third trimester rose to 16%.
Emotional
Support scale.
-Third trimester cohort:
Multiple
Baseline at the beginning of
psychosocial
the third trimester for probable
assessments
MDD 12.7% and decreased to
were given.
10.7% at the end of third
- Two cohorts trimester.
were used
throughout the -Both cohorts had comparable
rates at the postpartum visits:
study: a first
9.6% for first trimester and 8%
trimester
for third trimester.
cohort and a
third

number of patients
being screened.
-Integrated teambased approach to
prenatal care
decreased the
depressive
symptoms
pregnant and
postpartum
patients
experienced.

-This study may not be generalized to
other obstetric clinics that lack
resources
-EHR may have not captured every
interaction between patient and
provider
-Lack of socioeconomic diversity
among patient population
Strengths:
-Integrated team-based prenatal care
was helpful when screening and
referring patients for treatment.
-Use of EHR.

-Most incidence of
depressive
symptoms
occurred during
pregnancy which
was believed to
mostly be in
postpartum
patients in the
past.

-Clinic resources were available when
a patient screened positive.
Limitations:
-No psychiatric evaluation was
completed after the EPDS screening.
The EPDS is not a diagnostic tool.
Further evidence should utilize a
psychiatric diagnostic tool to measure
depression during pregnancy.
Strengths:
-Using internet-based assessments
was more convenient for pregnant
women and easy to assess or measure
the data.

Yu et al.,
2020.

Level
III
A

-longitudinal
study, 1126
pregnant
women around
13-weeks
gestation

-To measure
the trajectory
and onset of
depressive
symptoms
during early
pregnancy and
up to 6 weeks
postpartum.
-To assess the
patient’s
relationship,
demographic
information,
and
psychological
factors.

trimesters
cohort. Both
groups were
followed
through 12
weeks
postpartum.
This study
assessed mood
up to 15
timepoints
during
pregnancy to
measure the
changes in
mood during
pregnancy and
postpartum.

-Incidence cases of a score
>14 EPDS with a lower score
prior: 80% of these incidence
cases occurred during
pregnancy. 33% in the first
trimester, 24% in second
trimester, and 22% in third
trimester.

GAD-7 for
anxiety and
EPDS for
depression

-508 women completed all 7
assessments. 61.5% of them
experienced depressive
symptoms at least 1 time
during pregnancy and
postpartum.

-3 trajectories
were identified.
High antenatal,
high postpartum,
and low
throughout.

-52.4% first experienced
depressive symptoms during
early pregnancy.

Strengths:
-Pregnant women
should be screened -Validated findings in other research
like this study design.
and offered
intervention in
early pregnancy
which may change
a trajectory.

-Screening
took place at 7
different times
during
pregnancy and
postpartum.

-58.3% of the antenatal high
trajectory and 54.8% of the
postpartum high trajectory
experienced their first
depressive symptom in early
pregnancy.
-Antenatal high trajectory
peaked during the second
trimester.

Limitations:
-Response rate was low
-No clinical diagnosis data
-No data overtime

-Postpartum high trajectory
peaked at 7 days postpartum.

Gisseman et
al., 2021

Level
III
A

-Retrospective
cohort study,
4411 pregnant
women

-To assess the
rate and
effectiveness of
screening

EPDS
-First prenatal
visit, 28-week
visit, and 6week
postpartum
visit.

-Third trajectory was low
throughout.
-Screening rates: First prenatal
visit 96%, 28-week visit 60%,
and postpartum visit 84%.
-88% of EPDS scores >12 was
offered the appropriate
treatment.

-Standardization
of screening
recommendations
are needed in an
obstetric clinic to
ensure screening
rates are high.

Limitations:
-Follow up evaluations and diagnoses
were not included within this research
study which did not evidence of
outcomes after screening
-May not be able to generalize the
study to multiple obstetric clinics
since this study involves a specific
population of women seeking care at
a military hospital
Strengths:
-Standards of frequency and timing
were included in this obstetric setting.
-EPDS is a valid screening tool to
measure.

Miller et al.,
2021

Level
III
A

-Cohort study,
7,028
pregnant
women
included:
3,227 prior to
policy change
and 3,801
after.

-To evaluate if
perinatal
collaborative
care program
increased
screening and
treatment for
antenatal
depression

Unable to
determine
-1 screening
during the
prenatal
period

-Screening rates: Before
program 33% and after
program 81%

-Collaborative
perinatal care is a
feasible option
within obstetric
clinics. It helps
increase the
number of
screened and
treated pregnant
women. It may
also address a
broad list of
perinatal mental
health concerns.

Limitations:
-Future research should use RCT
methodology to evaluate the true
impact of the collaborative care
program
-The state where this study took place
mandated postpartum depression
screening in 2008 which may impact
awareness and screening rates.
-Results did not include whether
treatment was initiated or not.

Strengths:
-Large and diverse population of
women who included in the research

Guo et al.,
2021

Level
III
A

-Crosssectional
study, 5728
pregnant
women

-To identify the
prevalence and
risk factors of
antenatal
depression at
the first
antenatal visit

PHQ-9 and
GAD-7
-Screened at
first antenatal
visit- any
trimester.

-Percentage of women in each
trimester that participated:
First trimester 73%, Second
trimester 18%, and third
trimester 9%.
-Screening results: 16.3% of
women had postpartum
depression with the highest
rates being in the first
trimester 18.1%
-There was a lower risk of
antenatal depression in the
second and third trimester
when compared to the first
trimester.

LomonacoHaycraft et
al., 2018

Level
V
A

-Quality
improvement,
750 pregnant
women

-To evaluate
the program’s
effectiveness

EDPS
-Women were
screened
during a first
trimester visit,
28-week visit,
and 6-week
postpartum
visit.

-Screening rates: Intake visits
before program were 0%
screened and after the program
>75% screened
-Intake 93% were screened
48/223 were positive: 21.52%
-28-week visit 37% were
screened 17/106 were positive:
16.04%

-1 in 6 pregnant
women experience
depressive
symptoms.
-Risk factors to
consider for
perinatal
depression
screening were:
Early pregnancy,
anxiety symptoms,
somatic
symptoms, and
living in rural
areas.

-Implementing a
universal
screening program
for perinatal
mental health
disorders and
Integrated
behavioral health
is feasible.

-The study included a variety of
obstetric providers which allows the
evidence to be generalized to other
obstetric clinics
Limitations:
-cross-sectional study which did not
allow relationship with variables to be
studied
-Psychosocial factors that may also
impact depression during pregnancy
were not fully included within the
study
-Further study should include a
broader inclusion of psychosocial
factors that may influence depressive
symptoms during pregnancy and
dynamically assess depression during
different stages of pregnancy
Strengths:
-reliable results: Other studies have
similar results
Limitations:
-Need to track more outcomes in the
future to identify effectiveness
-not identifying other factors that
influence depression such as
childhood trauma
Strengths:
-Collaboration with interdisciplinary
groups to move the effort forwards.

-Quantitative data is strong indication
that women have a reduction in
depressive symptoms after the
implementation of the program

-6-week postpartum 60% were
screened 28/134 were positive:
20.89%

Ellington,
2021

Level
V
B

Mestard et
al., 2016

Level
III
A

-Quality
improvement,
77 first
trimester
pregnant
women

-Retrospective
cohort study,
245 pregnant
women

-To evaluate a
QI project after
initiating
universal
perinatal
depression
screening
during
pregnancy

EPDS

-To identify
what
proportion of
women
screened
positive once
and twice
during
pregnancy.

EPDS

-Intake
obstetric visit

-Screened at
the first
prenatal visit
and the 26week visit

-Screenings rates have
increased with more time after
the programs implementation
-Screening results: 24/77
women screened positive with
an elevated EPDS score.

-Screening rates: Number of
women screened once during
pregnancy 84% and number of
women screened twice during
pregnancy 50%
-27% of women screened
positive for depression once
during pregnancy
-19% of women screened
positive for depression twice
during pregnancy
-55 of the 56 women who
screened positive received a
referral to mental health
services

-Educating and
involving staff
was essential to
implementing the
changes.
-Screening
increases patients’
ability to have
access to the
mental health
services they need.
-Universal
perinatal
depression
screening during
pregnancy allows
more access to
mental health
resources as well
as social services
support.

Limitations:
-Only evaluating one obstetric clinic
Strengths:
-EMR allowed an easier transition
and helped prompt the screening for
patients required

Limitations:
-Those who did not receive adequate
screening were non-English speaking
-EPDS does include an assessment of
violence or neighborhood violence as
a risk factor for depression
-Social work training should continue
to study perinatal depression to
address these disparities
-Patients who were only screened
once usually enter prenatal care late
Strengths:
-Addressing a gap in the literature
which includes integrative team
approach to depression screening.

Table 2
Summarized Results.

Frequency and the Personal System




Timing and the Interpersonal System





Feasibility and the Social System




Most optimal frequency at every visit
during pregnancy.
Least optimal frequency is screening
once during pregnancy.
Most pregnant women screen highest
during the first trimester or intake visit.
Pregnant women score the lowest for
depression during the third trimester.
Women are more likely to have
depression in the first trimester.
A universal screening protocol screens a
higher number of pregnant women for
depression.
Universal screening increases the
number of women who access mental
health services.
Antepartum women are more likely to
seek treatment compared to postpartum
women.

